Clinical Trials Browser

Phase 1/2 × Withdrawn × Adrenal Cortex Hormones × Clear all

NCT02802163 2017-04-25

Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat

Phase 1/2 Withdrawn

Multiple Myeloma